79 related articles for article (PubMed ID: 1687025)
1. Synthesis and identification of a novel tetrazole metabolite of the angiotensin II receptor antagonist DuP 753.
Stearns RA; Doss GA; Miller RR; Chiu SH
Drug Metab Dispos; 1991; 19(6):1160-2. PubMed ID: 1687025
[No Abstract] [Full Text] [Related]
2. The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slices.
Stearns RA; Miller RR; Doss GA; Chakravarty PK; Rosegay A; Gatto GJ; Chiu SH
Drug Metab Dispos; 1992; 20(2):281-7. PubMed ID: 1352222
[TBL] [Abstract][Full Text] [Related]
3. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177.
Sechi LA; Grady EF; Griffin CA; Kalinyak JE; Schambelan M
J Hypertens Suppl; 1991 Dec; 9(6):S224-5. PubMed ID: 1818953
[No Abstract] [Full Text] [Related]
4. N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans.
Huskey SE; Miller RR; Chiu SH
Drug Metab Dispos; 1993; 21(5):792-9. PubMed ID: 7902238
[TBL] [Abstract][Full Text] [Related]
5. Microbial hydroxylation and glucuronidation of the angiotensin II (AII) receptor antagonist MK 954.
Chen TS; So L; White R; Monaghan RL
J Antibiot (Tokyo); 1993 Jan; 46(1):131-4. PubMed ID: 8436545
[TBL] [Abstract][Full Text] [Related]
6. Absorption and glucuronidation of the angiotensin II receptor antagonist losartan by the rat intestine.
Krieter PA; Colletti AE; Miller RR; Stearns RA
J Pharmacol Exp Ther; 1995 May; 273(2):816-22. PubMed ID: 7752085
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.
Yun CH; Lee HS; Lee H; Rho JK; Jeong HG; Guengerich FP
Drug Metab Dispos; 1995 Feb; 23(2):285-9. PubMed ID: 7736926
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
[No Abstract] [Full Text] [Related]
9. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
[TBL] [Abstract][Full Text] [Related]
10. Losartan for hypertension.
Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
[No Abstract] [Full Text] [Related]
11. Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.
Cannell RJ; Knaggs AR; Dawson MJ; Manchee GR; Eddershaw PJ; Waterhouse I; Sutherland DR; Bowers GD; Sidebottom PJ
Drug Metab Dispos; 1995 Jul; 23(7):724-9. PubMed ID: 7587961
[TBL] [Abstract][Full Text] [Related]
12. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.
Furtek CI; Lo MW
J Chromatogr; 1992 Jan; 573(2):295-301. PubMed ID: 1601963
[TBL] [Abstract][Full Text] [Related]
14. Identification of AT1 receptors on human platelets and decreased angiotensin II binding in hypertension.
Crabos M; Bertschin S; Bühler FR; Rogg H; Evéquoz D; Eberhard M; Erne P
J Hypertens Suppl; 1993 Dec; 11(5):S230-1. PubMed ID: 8158359
[No Abstract] [Full Text] [Related]
15. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
Munafo A; Christen Y; Nussberger J; Shum LY; Borland RM; Lee RJ; Waeber B; Biollaz J; Brunner HR
Clin Pharmacol Ther; 1992 May; 51(5):513-21. PubMed ID: 1587065
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with angiotensin II receptor antagonists.
Lee RJ; Brunner HR
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN
J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II antagonists: a new class of antihypertensive agent.
Waeber B; Brunner HR
Br J Clin Pract; 1996; 50(5):265-8. PubMed ID: 8794603
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor subtypes in bovine and human ventricular myocardium.
Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Yamada S; Inabe K; Kimura R; Suzuki H; Hoshino T
J Pharmacol Exp Ther; 1994 Aug; 270(2):566-71. PubMed ID: 8071849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
